CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology (CGON) posted Preferred Dividend Payments of $410000.0 for Q3 2023, down 89.14% on a QoQ basis from $3.8 million in Q2 2023.

CG Oncology (CGON) Preferred Dividend Payments (2023) Analysis & Trends

CG Oncology's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $410000.0 for Q3 2023.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $410000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2024 was $410000.0 (changed N/A YoY) and the FY2023 annual result came in at $410000.0, changed N/A from the prior year.
Preferred Dividend Payments was $410000.0 for Q3 2023 at CG Oncology, down from $3.8 million in the prior quarter.
Across five years, Preferred Dividend Payments topped out at $3.8 million in Q2 2023 and bottomed at $410000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	CG Oncology	5.86 Bn	5.86 Bn	-1.88 Mn	-

Download Data